Vanguard Group Inc Nexgel, Inc. Call Options Transaction History
Vanguard Group Inc
- $6.44 Trillion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NXGL
# of Institutions
19Shares Held
566KCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY87.1KShares$166,3680.0% of portfolio
-
Geode Capital Management, LLC Boston, MA66.4KShares$126,7640.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny63.5KShares$121,1930.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA43.6KShares$83,3250.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA38KShares$72,6040.02% of portfolio
About NEXGEL, INC.
- Ticker NXGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 5,572,230
- Market Cap $10.6M
- Description
- NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was...